In cancer cells, PDPN enhances the tumor metastatic potential by eliciting tumor cell-induced platelet aggregation through activation of the platelet receptor, CLEC-2 (C-type lectin-like receptor 2)18. The gene discussed is CLEC1B; the disease is neoplasm.